© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY · WNPR
WPKT · WRLI-FM · WEDW-FM · Public Files Contact
ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

First Cases Of New, Infectious Fungus Reported In U.S.

<em>Candida auris</em> is a fungus that can cause invasive infections, is associated with high mortality and is often resistant to multiple antifungal drugs, says the Centers for Disease Control and Prevention.
CDC
Candida auris is a fungus that can cause invasive infections, is associated with high mortality and is often resistant to multiple antifungal drugs, says the Centers for Disease Control and Prevention.

If you're tracking emerging infectious agents in the United States, it's time to add a new one to the list.

The Centers for Disease Control and Prevention has identified 13 cases of a fungal infection first seen in Japan in 2009. The culprit is called Candida auris.

The fungus has appeared among hospitalized patients with cancer-damaged immune systems or other serious conditions.

Four patients died of the seven the CDC examined in detail. Because they were all quite ill to begin with, it's not clear that the fungus caused their deaths.

"We need to act now to better understand, contain and stop the spread of this drug-resistant fungus," CDC Director Tom Frieden said in a statement. "This is an emerging threat, and we need to protect vulnerable patients and others."

The CDC reported details of these seven cases Friday in an early release of the center's Morbidity and Mortality Weekly Report.

One concern: It appears that in two instances, the fungus may have spread within hospitals. Two cases appeared in an unidentified Illinois hospital. Two cases were also identified in an unidentified New Jersey hospital. These aren't ironclad cases however. In both instances, the patients were on different wards within the same hospital.

The fungus is also hard to identify, though you have to admit that the diagnostic methods sound pretty spiffy. Labs can use "matrix-assisted laser desorption/ionization time-of-flight" analysis, or, if that's not handy, they can sequence the D1-D2 region of the fungus' 28s ribosomal DNA.

The CDC report notes that since the fungus was first identified in Japan seven years ago, it has been detected in Colombia, India, Israel, Kenya, Kuwait, Pakistan, South Africa, South Korea, Venezuela and the United Kingdom.

Many samples of this fungus turn out to be resistant to multiple drugs, though the U.S. cases all responded to at least one antifungal agent.

In June, the CDC asked hospital labs to be on the lookout for this emerging disease. Indeed, five of the seven known cases in the U.S. appeared in 2016.

The CDC used its report to remind health care facilities to use well-established infection-control measures, including thorough daily cleaning of patient rooms with disinfectants active against fungi.

Updated 3:21 p.m.: The post was updated to include six cases the CDC mentioned in a media release but didn't study in detail.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Related Content